Boston Partners’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-609,887
Closed -$1.49M 778
2022
Q3
$1.49M Buy
609,887
+399,255
+190% +$1.33M ﹤0.01% 472
2022
Q2
$478K Sell
210,632
-4,995
-2% -$18.6K ﹤0.01% 609
2022
Q1
$1.45M Sell
215,627
-2,667
-1% -$22.8K ﹤0.01% 503
2021
Q4
$1.98M Sell
218,294
-36,491
-14% -$339K ﹤0.01% 461
2021
Q3
$2.58M Sell
254,785
-3,850
-1% -$42.2K ﹤0.01% 430
2021
Q2
$3.32M Buy
258,635
+46,941
+22% +$644K ﹤0.01% 404
2021
Q1
$2.99M Sell
211,694
-195
-0.1% -$2.69K ﹤0.01% 432
2020
Q4
$2.26M Sell
211,889
-4,021
-2% -$36.5K ﹤0.01% 424
2020
Q3
$1.65M Sell
215,910
-18,127
-8% -$133K ﹤0.01% 445
2020
Q2
$1.42M Buy
+234,037
New +$1.15M ﹤0.01% 472

Other funds holding DBD

Boston Partners's DBD Position: Q4 2022 in Review

Boston Partners sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 609,887 shares — an estimated $1.49M sold.

Boston Partners first reported a position in DBD in Q2 2020 and held it in 10 quarters. The position peaked at $3.32M in Q2 2021. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Boston Partners reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Boston Partners sold 609,887 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $1.49M.
  • Boston Partners first reported a position in Diebold Nixdorf Incorporated in Q2 2020 and held it in 10 quarters.
  • Boston Partners's Diebold Nixdorf Incorporated position peaked at $3.32M in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.